NYSE:CHEHealthcare
Is It Time To Reconsider Chemed (CHE) After Recent 11.8% Share Price Jump?
Investors may be wondering whether Chemed, at around US$422 per share, still lines up with its underlying worth or if the recent price is out of step with fundamentals.
Over the last month the stock is up 11.8%, even though the 1 year return sits at a 26.3% decline and the year to date return is roughly flat at a 0.4% decline.
Recent coverage around Chemed has focused on its role in healthcare services and how investors are weighing that profile against a weaker 1 year share price...